PMS2 and colorectal carcinoma: In 29 CRC patients, we evaluated the loss or retained expression of MMR proteins in CRC tissue assessed through immunohistochemistry, and we found that only one patient had a loss of protein expression of PMS2 and MLH1 (Supplementary Table S3).